Alzheimer's Disease

Clinical Trials

Below is a list of Alzheimer's Disease clinical trials from the clinical trials database at Mayo Clinic.

Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

Alzheimer's Disease Neuroimaging Initiative 2
The Alzheimer's Disease Neuroimaging Initiative (ADNI) began in October 2004 as a landmark study with a public-private partnership that gathered and analyzed thousands of brain scans, genetic profiles and biomarkers in blood and cerebrospinal fluid (CSF).
Read more

Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
This project continues the work from ADNI1, the goal of which is to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessments can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD).
Read more

Receptor for Glycation End Products (RAGE)
This study is being done to evaluate whether the use of the study medicine PF-04494700 is able to change the rate of cognitive decline in subjects with Alzheimer's disease (AD). In this study, people with AD will be given placebo (a pill that does not have any drug) or one of two doses of PF-04494700 for 18 months to determine whether daily PF-04494700 therapy
Read more